QUESTCOR PHARMACEUTICALS, INC.
🏢 View company profile →7Patents
3Active
7Granted
36Portfolio score
Filing activity: Aug 24, 1999 → Jun 24, 2014 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6770262B2 | Nasal administration of agents for the treatment of gastroparesis | Human Necessities | 10 | Expired |
| US7608616B1 | Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia | Human Necessities | 4 | Active |
| US6410715B1 | Methods for treating hormone disorders | Physics | 4 | Expired |
| US8796416B1 | ACTH prophylactic treatment of renal disorders | Chemistry; Metallurgy | 2 | Active |
| US6251898A | Medical use of fluorenone derivatives for treating and preventing brain and spinal injury | Chemistry; Metallurgy | 2 | Expired |
| US6312707A | Treatment of sickle cell anemia crises with fructose-1,6-diphosphate as an analgesic drug | Human Necessities | 1 | Expired |
| US9550822B2 | ACTH prophylactic treatment of renal disorders | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.